UK – NICE publishes new COVID-19 guidelines

The National Institute of Health and Care Excellence (NICE) has published new rapid COVID-19 guidelines covering the management of disorders of the digestive system treated with drugs that affect the immune response, and the care of people in hospital who develop heart problems as a consequence of COVID-19 infection.

The guideline on gastrointestinal and liver conditions provides clinicians with advice on how to adjust care to reduce patients’ exposure to COVID-19 and how to balance the risks and benefits of taking drugs that affect the immune response during the pandemic.